Ravindra Taware
Overview
Explore the profile of Ravindra Taware including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saklani S, Chaudhari S, Shukla G, Gound H, Awasarmol D, Taware R
Mol Divers
. 2024 Oct;
PMID: 39476277
Parasitic diseases remain a significant global health challenge, especially in developing countries, contributing to approximately one million deaths annually. Notably, among the 143 FDA-approved antiparasitic drugs, thirty-four possess chlorine in...
2.
Bhavsar V, Sahu A, Taware R
Mol Cell Biochem
. 2024 Sep;
PMID: 39302488
EVs (extracellular vesicles) are phospholipid bilayer vesicles that can be released by both prokaryotic and eukaryotic cells in normal as well as altered physiological conditions. These vesicles also termed as...
3.
Taunk K, Taware R, More T, Porto-Figueira P, Pereira J, Mohapatra R, et al.
RSC Adv
. 2022 May;
8(44):25040-25050.
PMID: 35542123
Worldwide, breast invasive ductal carcinoma (IDC) accounts for the majority of the reported cases of this form of cancer. IDC effective management, as for any form of cancer, would greatly...
4.
Chanukuppa V, More T, Taunk K, Taware R, Chatterjee T, Sharma S, et al.
RSC Adv
. 2022 May;
9(51):29522-29532.
PMID: 35531512
Multiple myeloma (MM) is the second most prevalent hematological malignancy characterized by rapid proliferation of plasma cells, which leads to overproduction of antibodies. MM affects around 15% of all hemato-oncology...
5.
Taware R, More T, Bagadi M, Taunk K, Mane A, Rapole S
RSC Adv
. 2022 Apr;
11(1):397-407.
PMID: 35423059
The need of identifying alternative therapeutic targets for invasive ductal carcinoma (IDC) of the breast with high specificity and sensitivity for effective therapeutic intervention is crucial for lowering the risk...
6.
Taunk K, Porto-Figueira P, Pereira J, Taware R, da Costa N, Barbosa R, et al.
Metabolites
. 2022 Jan;
12(1).
PMID: 35050157
The urinary volatomic profiling of Indian cohorts composed of 28 lung cancer (LC) patients and 27 healthy subjects (control group, CTRL) was established using headspace solid phase microextraction technique combined...
7.
Chanukuppa V, Taware R, Taunk K, Chatterjee T, Sharma S, Somasundaram V, et al.
Front Oncol
. 2021 Feb;
10:566804.
PMID: 33585190
Multiple myeloma (MM) is a plasma cell-associated cancer and exists as the second most common hematological malignancy worldwide. Although researchers have been working on MM, a comprehensive quantitative Bone Marrow...
8.
Pereira J, Porto-Figueira P, Taware R, Sukul P, Rapole S, Camara J
Molecules
. 2020 Jul;
25(13).
PMID: 32646009
Fostered by the advances in the instrumental and analytical fields, in recent years the analysis of volatile organic compounds (VOCs) has emerged as a new frontier in medical diagnostics. VOCs...
9.
Taware R, Taunk K, Kumar T, Pereira J, Camara J, Nagarajaram H, et al.
Metabolomics
. 2020 Jan;
16(2):21.
PMID: 31980945
Introduction: The metabolic shift induced by hypoxia in cancer cells has not been explored at volatilomic level so far. The volatile organic metabolites (VOMs) constitute an important part of the...
10.
More T, Taware R, Taunk K, Chanukuppa V, Naik V, Mane A, et al.
Metabolomics
. 2019 Mar;
14(8):107.
PMID: 30830381
Introduction: Invasive ductal carcinoma (IDC) is a type of breast cancer, usually detected in advanced stages due to its asymptomatic nature which ultimately leads to low survival rate. Identification of...